Coloplast shares are up nearly 8% since the Danish medical device company reported its 4th-quarter and fiscal 2013 results.
Coloplast (CPH:COLO B) shares have gained nearly 8% since the Danish medical device company reported profit growth of more than 23% for the fiscal 4th quarter and 2013 last week.
A federal judge in West Virginia sets a date early next year for the 1st bellwether case in the multi-district litigation filed over Boston Scientific's pelvic mesh products.
The 1st bellwether trial in the multi-district litigation filed over Boston Scientific's (NYSE:BSX) pelvic mesh products is slated for early next year, a federal judge ordered this week.
Makers of pelvic mesh facing 10s of thousands of lawsuits over the surgical devices are hoping to negotiate bulk settlements with a consortium of plaintiffs' lawyers, according to Bloomberg.
Five medical device companies that make pelvic mesh implants are hoping to negotiate settlements for the more than 30,000 pending lawsuits they're facing in the U.S., anonymous sources told Bloomberg.
A lawsuit against Analytical Biosurgical Solutions, a French maker of the mesh used in Coloplast's transvaginal mesh, is dismissed from a personal injury lawsuit filed against Coloplast.
The French manufacturer of the mesh used in Coloplast's embattled Aris transobturator tape system was dismissed from one of the thousands of personal injury lawsuits filed over pelvic mesh systems.
A federal judge denies Coloplast's motion to dismiss a personal injury lawsuit filed over the Virtue ventral urethral elevation sling.
Coloplast (CPH:COLO B) can't dodge a personal injury lawsuit filed in a Colorado federal court over its Virtue urethral sling, but the majority of the counts and moves for legal fees and punitive damages were stricken from the case.
Agilent Technologies pays $2.2 billion for Dako, a Denmark-based cancer diagnostics developer, marking the largest deal in Agilent history.
MASSDEVICE ON CALL — Agilent Technologies (NYSE:A) doled out more than $2 billion in cash to acquire Dako, a Denmark-based cancer diagnostic company with more than 1,000 employees with a foothold in more than 100 countries.
The deal, intended to grow Agilent's life sciences business, is the largest in the company's history, according to a press release.